Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" ...

Researchers examined the risk for serious infection among patients with atopic dermatitis treated with Janus kinase inhibitors vs Th2 cytokine inhibitors.

The effects of tumor necrosis factor inhibition on carcinogenesis and tumor progression are incompletely understood. In 2009, an analysis by the FDA suggested an increased risk of cancer in ...

ORLANDO, Fla. — Of the 12 biologics in four drug classes approved for treating psoriasis in the United States, interleukin 23 (IL-23) inhibitors might be exceptional, particularly if used early ...

Targeting the immune system through modulation of cytokine signalling has been a cornerstone of therapeutic innovation for autoimmune diseases over the past 25 years, exemplified by the success of ...

Cytokine interaction networks drive immune function, but they are difficult to map and study. Not only are these networks complex, but they are built by molecules that typically exist in low ...

Stem cells are multipotent cells with the ability to self-renew, self-replicate, and differentiate into multiple cell lines, including MSCs, HSCs, NSCs, ESCs, and iPSCs. Remarkable progress has been ...

Breast cancer is the most frequently diagnosed cancer and contributes to 15 percent of all cancer-related deaths in women worldwide. Though 20–30 percent of patients with early-stage breast cancers ...